FDA Notices of Judgment Collection, 1908-1966

4122. Misbranding of dextro-amphetamine sulfate tablets and secobarbital sodium capsules. U. S. v. Clyde King (Clyde King Drug Co.), and Benjamin H. Darnell. Pleas of guilty. Fine of $50 against each defendant.